Zai Lab Limited (HKG:9688)
14.12
+0.61 (4.52%)
At close: Mar 27, 2026
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 15.36 billion as of March 27, 2026. Its market cap has decreased by -48.88% in one year.
Market Cap
15.36B
Enterprise Value
11.72B
Revenue
3.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.12
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 15.36B, an increase of 1,030.23%. That is a compound annual growth rate of 32.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 15.36B | 0.57% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Pharma | 25.02B |
| Genscript Biotech | 24.07B |
| Duality Biotherapeutics | 23.08B |
| PegBio | 23.00B |
| Ascletis Pharma | 17.26B |
| Keymed Biosciences | 16.98B |
| Ascentage Pharma Group International | 15.74B |
| Nanjing Leads Biolabs | 13.39B |